Facebook
Twitter
LinkedIn
ForwardPediatrics
Pediatric radiation oncology requires a thoughtful integration of multi-modality care considerations into the radiation treatment paradigm. While most cases will follow protocol scripted treatment guidelines, case specific considerations are sometimes required to address competing concerns related to the morbidity of combined modality care and achieving favorable disease control. Recent trials highlight the need to continue to refine the therapeutic ratio of radiotherapy for children and adolescents, although variable success has been encountered with both treatment intensification and de-escalation. We will review recent trials as they relate the current standard of care as well as clarify ongoing research questions which are currently being evaluated in ongoing studies.
Target Audience
The meeting is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, radiation therapists, radiation dosimetrists, nurses and all other health professionals involved in the field of radiation oncology.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
- Identify recent trials in the field of pediatric radiation oncology.
- Evaluate recent trials in the field of pediatric radiation oncology.
Faculty:
A list of all meeting faculty and Individual presenter disclosures can be found on the Schedule of Events page.
Planning Committee:
A list of all meeting planning committee members and their individual disclosures can be found on the Planning Committee webpage.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
- 0.75 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.75 Certificate of AttendanceThis activity was designated for 0.75 AMA PRA Category 1 Credit™.